View Item 

Show simple item record

Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis
dc.contributor.authorCowen, E. W.en_US
dc.contributor.authorLiu, C-W.en_US
dc.contributor.authorSteinberg, S. M.en_US
dc.contributor.authorKang, S.en_US
dc.contributor.authorVonderheid, E. C.en_US
dc.contributor.authorKwak, H. S.en_US
dc.contributor.authorBooher, S.en_US
dc.contributor.authorPetricoin, E. F.en_US
dc.contributor.authorLiotta, L. A.en_US
dc.contributor.authorWhiteley, G.en_US
dc.contributor.authorHwang, S. T.en_US
dc.date.accessioned2010-06-01T18:39:06Z
dc.date.available2010-06-01T18:39:06Z
dc.date.issued2007-11en_US
dc.identifier.citationCowen, E.W.; Liu, C-W.; Steinberg, S.M.; Kang, S.; Vonderheid, E.C.; Kwak, H.S.; Booher, S.; Petricoin, E.F.; Liotta, L.A.; Whiteley, G.; Hwang, S.T. (2007). "Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis." British Journal of Dermatology 157(5): 946-953. <http://hdl.handle.net/2027.42/71852>en_US
dc.identifier.issn0007-0963en_US
dc.identifier.issn1365-2133en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71852
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17854367&dopt=citationen_US
dc.format.extent142430 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal Compilation 2007 British Association of Dermatologists No claim to original US government worksen_US
dc.subject.otherMycosis Fungoidesen_US
dc.subject.otherProteomicsen_US
dc.subject.otherPsoriasisen_US
dc.titleDifferentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysisen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum† Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, U.S.A.en_US
dc.contributor.affiliationotherDermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, U.S.A.en_US
dc.contributor.affiliationother* SAIC-Frederick, Inc., Clinical Proteomics Reference Laboratory, Gaithersburg, MD, U.S.A.en_US
dc.contributor.affiliationother† Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Rockville, MD, U.S.A.en_US
dc.contributor.affiliationother§ Departments of Dermatology and Oncology, Johns Hopkins Medical Institutes, Baltimore, MD, U.S.A.en_US
dc.contributor.affiliationother¶ Center for Applied Proteomics and Molecular Medicine, Department of Molecular and Microbiology, George Mason University, Manassas, VA, U.S.A.en_US
dc.identifier.pmid17854367en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71852/1/j.1365-2133.2007.08185.x.pdf
dc.identifier.doi10.1111/j.1365-2133.2007.08185.xen_US
dc.identifier.sourceBritish Journal of Dermatologyen_US
dc.identifier.citedreferencePetricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572 – 7.en_US
dc.identifier.citedreferenceSimpkins F, Czechowicz JA, Liotta L et al. SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics. Pharmacogenomics 2005; 6: 647 – 53.en_US
dc.identifier.citedreferenceRicolleau G, Charbonnel C, Lode L et al. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors. Proteomics 2006; 6: 1963 – 75.en_US
dc.identifier.citedreferenceAlbitar M, Potts SJ, Giles FJ et al. Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer 2006; 106: 1587 – 94.en_US
dc.identifier.citedreferenceEspina V, Dettloff KA, Cowherd S et al. Use of proteomic analysis to monitor responses to biological therapies. Expert Opin Biol Ther 2004; 4: 83 – 93.en_US
dc.identifier.citedreferenceWillemze R, Jaffe ES, Burg G et al. WHO–EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768 – 85.en_US
dc.identifier.citedreferenceVonderheid EC, Diamond LW, Lai SM et al. Lymph node histopathologic findings in cutaneous T-cell lymphoma. A prognostic classification system based on morphologic assessment. Am J Clin Pathol 1992; 97: 121 – 9.en_US
dc.identifier.citedreferenceFraser-Andrews EA, Woolford AJ, Russell-Jones R et al. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000; 114: 117 – 21.en_US
dc.identifier.citedreferenceMuche JM, Lukowsky A, Asadullah K et al. Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 1997; 90: 1636 – 42.en_US
dc.identifier.citedreferenceZackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. J Am Acad Dermatol 2002; 47: 914 – 18.en_US
dc.identifier.citedreferenceBunn PA Jr, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63: 725 – 8.en_US
dc.identifier.citedreferenceZackheim HS, Amin S, Kashani-Sabet M et al. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol 1999; 40: 418 – 25.en_US
dc.identifier.citedreferenceKoo JY. Current consensus and update on psoriasis therapy: a perspective from the U.S. J Dermatol 1999; 26: 723 – 33.en_US
dc.identifier.citedreferenceSchon MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352: 1899 – 912.en_US
dc.identifier.citedreferenceFredriksson T, Pettersson U. Severe psoriasis – oral therapy with a new retinoid. Dermatologica 1978; 157: 238 – 44.en_US
dc.identifier.citedreferenceDiamandis EP. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 2004; 96: 353 – 6.en_US
dc.identifier.citedreferenceCarlen LM, Sanchez F, Bergman AC et al. Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis. J Invest Dermatol 2005; 124: 63 – 9.en_US
dc.identifier.citedreferenceFujii K, Kondo T, Yokoo H et al. Protein expression pattern distinguishes different lymphoid neoplasms. Proteomics 2005; 5: 4274 – 86.en_US
dc.identifier.citedreferenceCussac D, Pichereaux C, Colomba A et al. Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers. Proteomics 2006; 6: 3210 – 22.en_US
dc.identifier.citedreferenceFan G, Molstad M, Braziel RM et al. Proteomic profiling of mature CD10+ B-cell lymphomas. Am J Clin Pathol 2005; 124: 920 – 9.en_US
dc.identifier.citedreferenceLopez Z, Mikulskis A, Kuzdzal S et al. A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples. Clin Chem 2007; 53: 1067 – 74.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2133.2007.08185.x.pdf
Size:
139.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.